Record Display for the EPA National Library Catalog

RECORD NUMBER: 4 OF 8

OLS Field Name OLS Field Data
Main Title Evidence for Monoaminergic Involvement in Triadimefon-Induced Hyperactivity.
Author Crofton, K. M. ; Boncek, V. M. ; Macphail, R. C. ;
CORP Author Health Effects Research Lab., Research Triangle Park, NC. ;Northrop Services, Inc./Environmental Sciences, Research Triangle Park, NC.
Publisher c1989
Year Published 1989
Report Number EPA/600/J-89/396;
Stock Number PB90-245986
Additional Subjects Toxicology ; Fungicides ; Laboratory animals ; Enzyme inhibitors ; Reserpine ; Central nervous system ; Reprints ; Monoamines ; Triadimefon ; Hyperactivity ; Motor activity ; Dose-response relationships ; Tyrosine hydroxylase ; Drug antagonism
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB90-245986 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. 12/03/1990
Collation 6p
Abstract
Triadimefon is a triazole fungicide that produces hyperactivity in both mice and rats similar to that seen following administration of compounds with catecholaminergic activity (e.g., d-amphetamine). To determine whether the triadimefon-induced hyperactivity is due to an action on CNS catecholaminergic systems, the effects of combined treatment of triadimefon with either the tyrosine hydroxlase inhibitor d,l-alpha-methyl-p-tyrosine methyl ester HCl (alphaMPT) or the amine depletor reserpine were evaluated. Adult male Long-Evans hooded rats, approximately 70 days of age were used. Dosage-effect functions were determined for alphaMPT (0-200 mg/kg IP), reserpine (0-2.5 mg/kg IP), d-amphetamine (0-3 mg/kg IP), and methylphenidate (0-40 mg/kg IP). Motor activity was measured as photocell interruptions in figure-eight mazes. The interaction between triadimefon and alphaMPT was determined with the following groups: (1) vehicle control; (2) 200 mg/kg triadimefon PO; (3) 100 mg/kg alphaMPT; and (40 both alphaMPT and triadimefon. A similar design was used to determine the interaction between triadimefon and reserpine (0.62 mg/kg) alphaMPT and d-amphetamine (1.5 mg/kg), and reserpine and methylphenidate (5.0 mg/kg). (Copyright (c) Springer-Verlag 1989.)